Chemobrain: It’s Not Your Imagination
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
Progress Against Cancer
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success for many patients, immunotherapy still has challenges to overcome. Fortunately, novel strategies to improve the efficacy...
The immune systems of people with blood cancer respond differently to the coronavirus than the immune systems of people without cancer.
The launch of a campaign to address the decline in cancer screening rates, and more news of the week from Cancer Today.
A study indicates that people are delaying medical care until they are eligible for Medicare, and more news of the week from Cancer Today.
Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and more news of the week from Cancer Today.
A study indicates breast cancer centers often recommend earlier and more frequent screening than national guidelines, and more news of the week from Cancer Today.
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx liquid biopsy tests to detect genetic abnormalities over multiple tumor types, the use of liquid...
Lung cancer screening recommendations expand to include more smokers, and more news of the week from Cancer Today.
By Nicholas Warren, PhD Lung cancer is the deadliest cancer in the United States, killing more than 135,000 Americans every year. More than half of all lung cancers are diagnosed after the cancer has...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 48,000 members worldwide drive progress against cancer.
Donate Now